17alpha-estradiol is an estradiol that is estra-1,3,5(10)-triene substituted by hydroxy groups at positions 3 and 17 (the 17alpha stereoisomer). It has a role as a geroprotector and an estrogen. It is an estradiol, a 17alpha-hydroxy steroid and a 3-hydroxy steroid.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
GHS classification
GHS Classification · 5 items
This chemical does not meet GHS hazard criteria for 1.9% (3 of 154) of reports.
Danger
H350 (11.7%): May cause cancer [Danger Carcinogenicity]
P203, P260, P263, P264, P270, P280, P318, P319, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 154 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Regulatory InformationEstra-1,3,5(10)-triene-3,17-diol, (17.alpha.)-: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesCarc. 1A (11.7%)
Toxicology
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
USGS Health-Based Screening Levels for Evaluating Water-Quality · 3 items
17-alpha-Estradiol
Hormone
Smith, C.D. and Nowell, L.H., 2024. Health-Based Screening Levels for evaluating water-quality data (3rd ed.). DOI:10.5066/F71C1TWP
Safety data
F
8-10
PPE
dust mask type N95 (US), Eyeshields, Gloves
wgk
3
rtecs
KG3750000
Chemistry & industry
Pharmacology
Mechanism of Action · 1 item
MITO-4509 is an orally-administered drug candidate that shows neuro-protective activity and reductions in beta-amyloid in animal models of Alzheimer's disease, and is well tolerated in a completed human Phase I trial. In addition to Alzheimer's disease, MITO-4509 shows potential for use in Parkinson's disease, Friedreich's ataxia, retinitis pigmentosa, and mild cognitive impairment ("MCI" is often considered a precursor to Alzheimer's disease).
MeSH Pharmacological Classification · 2 items
Drugs used to treat or prevent skin disorders or for the routine care of skin.
Drugs that inhibit 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE. They are commonly used to reduce the production of DIHYDROTESTOSTERONE.
Cellular LocationsExtracellular
Uses & manufacturing
UsesUse (kg; approx.) in Germany (2009): >10
Applications · 1 item
UsesEstradiol (known as α-Estradiol or 17 α-Estradiol) is a biologically active estrogen in human breast cancer cells in tissue culture. 17-Εstradiol and its selective receptor, ER-X, are not part of a classical hormone/receptor endocrine system but of a system with important autocrine/paracrine functions in the developing and adult brain. 17-Estradiol may have enormous implications for hormone replacement strategies at the menopause and in the treatment of such neurodegenerative disorders as Alzheimer’s disease and ischemic stroke.